A B S T R A C T Sex differences and steroid hormones are known to influence the vascular system as shown by the different incidence of atherosclerosis in men and premenopausal women, or by the increased risk of cardiovascular diseases in women taking birth control pills or men taking estrogens. However, the mechanisms for these effects in vascular tissues are not known. Since steroid actions in target tissues are mediated by receptors, we have looked for cytoplasmic steroid receptor proteins in vascular tissues of dogs. We find specific saturable receptors, sedimenting at 8S on sucrose density gradients for estrogens (measured with [3H] We hypothesize that steroid hormones can have direct effects on vascular tissues mediated by specific receptors present in arterial blood vessel walls.
A B S T R A C T Sex differences and steroid hormones are known to influence the vascular system as shown by the different incidence of atherosclerosis in men and premenopausal women, or by the increased risk of cardiovascular diseases in women taking birth control pills or men taking estrogens. However, the mechanisms for these effects in vascular tissues are not known. Since steroid actions in target tissues are mediated by receptors, we have looked for cytoplasmic steroid receptor proteins in vascular tissues of dogs. We find specific saturable receptors, sedimenting at 8S on sucrose density gradients for estrogens ( R5020 and dihydrotestosterone). Progesterone receptors can, however, be induced by 1-wk treatment of dogs with physiological estradiol concentrations (100 pg/ml serum estrogen), indicating a functional estsogen receptor. Receptor levels range from 20 to 2,000 fmol/mg DNA. They are specific for each hormone; unrelated steroids fail to compete for binding. Low dissociation constants, measured by Scatchard analyses, show that binding is of high affinity. Steroid binding sites are in the media and/or adventitia since they persist when the intima is removed. Compared with the arteries, receptor levels are reduced 80% in inferior venae cavae of females, and are absent in the venae cavae of males.
We hypothesize that steroid hormones can have direct effects on vascular tissues mediated by specific receptors present in arterial blood vessel walls. INTRODUCTION There is epidemiological and experimental evidence that most steroid hormones, including the estrogens, Received for publication 25 September 1981 and in revised form 30 November 1981. progestins, androgens, and glucocorticoids, have important cardiovascular effects. The incidence of coronary artery disease, which is very low in young women, increases abruptly after menopause when endogenous production of estrogens and progestins is sharply reduced (1) (2) (3) (4) . Paradoxically, administration of exogenous pharmacologic estrogen and progesterone results in increased susceptibility to myocardial infarctions and strokes in women and men (5) (6) (7) (8) (9) . Estrogen alters hemodynamics in women and in experimental animals (10) (11) (12) . Exogenous androgen, estrogen, or progesterone cause morphological and histochemical changes in animal aortas (13) (14) (15) . Exogenous glucocorticoids or conditions characterized by excessive endogenous glucocorticoid production may be associated with systemic hypertension (16) (17) (18) .
The mechanism by which these steroid hormones influence the cardiovascular system is not known. It has been proposed that steroid hormones affect the cardiovascular system indirectly, either through release of vasoactive endogenous substances, such as prostaglandins or histamine (19) (20) (21) , or through alterations in lipid metabolism (22) .
In this study we (24) , and glucocorticoid receptors (GLUC R) are ubiquitous, reflecting the manifold actions of these hormones (25) . We sought to assess whether portions of the vascular bed could also serve as direct target organs for these steroids. We (27) , using calf thymus DNA as a standard.
Receptor assays. Cytoplasmic steroid receptors were assayed using sucrose density gradients as previously described (28 [30] ) of R1881. A 10-fold excess of dihydrotestosterone was added to cytosols to mask androgen binding sites when R5020 was used to measure PR (29) .
Pellets were prepared from a 1-ml suspension of dextrancoated charcoal (0.25% Norit A, 0.0025% dextran in 10 mM Tris-HCI, pH 8.0 at 4°C) by a 10-min centrifugation at 3,200 rpm (2,000 g). The supernatant buffer was discarded, and the labeled cytosol was transferred onto the pellet, mixed, and incubated for 10 min to adsorb unbound radioactivity.
After centrifugation for 10 min, a 200-Al aliquot of the supernatant cytosol was layered over a linear 5-20% sucrose gradient prepared in homogenization buffer. Discontinuous gradients were prepared manually at room temperature in 4.0-ml polyallomer tubes or 5.1-ml Quick Seal tubes (Beckman Instruments, Inc., Palo Alto, CA) and allowed to diffuse at 4°C overnight. Labeled '4C-BSA (New England Nuclear), 1 ,500 cpm/5 Al buffer, was added to each cytosol as an internal sedimentation (4.6S) marker. Quick Seal tubes were overlain with 100 Al cold water before they were sealed.
Gradients were centrifuged in a Beckman SW 60 rotor at 53,000 rpm (297,000 g) for 16.3 h, or in a Beckman gradient reorienting rotor at 65,000 rpm (404,000 g) for 2 h. Fractions (200 AI) were collected from the bottom of the tubes by oil displacement and counted in 5 ml Redi-Solv HP (Beckman) in a Beckman LS 4500 with an efficiency for tritium of 48% and for 14C of 89%. Generally, 24 Scatchard (31) . The X intercept (number of sites) and inverse slope (binding affinity expressed as the dissociation constant, Kd) were calculated from the best-fit line determined by linear regression analysis.
Competition studies. To assess receptor specificity, the appropriate radioactive hormones were incubated with cytosols, either alone, or together with 100-fold doses of a variety of unlabeled competitors. The binding in the 8S region of gradients in the absence of unlabeled competitors was set at 100%, and the binding in the presence of unlabeled steroids was compared to this.
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RESULTS
Characterization of the steroid receptors in aorta.
As Fig. 1 clearly shows, cytosols prepared from dog aortas have receptors for estrogens, androgens, and glucocorticoids. From the internal 14C-BSA marker, the sedimentation coefficients (s2o.w) for each class of receptors were calculated to be 8.5S for ER, 7.1S for AR, and 7.5S for GLUC R. These values are characteristic for these receptors in other tissues that we (29, 32) and others (23) have studied. This figure also shows that the binding of the labeled hormones in the 7-8S region is specific and of low capacity since it is completely eliminated in the presence of 100-fold excess of the appropriate unlabeled hormone. In contrast, hormone binding at the top of the gradient is to low affinity sites and cannot be displaced. From the area under the curve we calculate that the number of sites in the examples shown in Fig. 1 Table III) .
Scatchard analyses of the binding data obtained at various ligand concentrations are shown in Fig. 2 . The plots are linear, suggesting that each hormone is binding to a single class of sites. In these cytosols the number of specific receptors at saturation (B,p), calculated from the X intercept, were 165.3 fmol/mg DNA of ER, 25.3 fmol/mg DNA of AR, and 1,314.5 fmol/mg DNA of GLUC R. From the slope, the calculated dissociation constants (Kd), are 0.49 nM for ER, 0.53 nM for AR, and 54.1 nM for GLUC R. These values are similar to ones obtained for these receptors in other systems (23, 28) , and mean that binding is of high affinity, a characteristic of steroid receptor interactions with hormone.
To demonstrate that three distinct classes of receptors were being measured, each hormone class was used as a competitor for the others (Table I) :
Estrogen receptors. Only diethylstilbestrol (an estrogen that does not bind sex steroid binding globulin) was able to compete for binding of [3H]estradiol. The glucocorticoids and progestin were ineffective. Androgens at high doses (400 nM was used here) are known to have some affinity for ER (33) .
Glucocorticoid receptors. The glucocorticoids (dexamethasone and triamcinolone acetonide) were effective competitors as expected, and diethylstilbestrol failed to compete. However, the synthetic androgen, and the progestins were also effective competitors. Competition of 19-nor-androgens (R1881), 19 nor-progestins (R5020), and progesterone for glucocorticoid receptors has been noted previously (28, 34) , and the action of progesterone as an allosteric inhibitor of glucocorticoid action is well known (35) . This occurs at high doses (note that the concentration of competitors used was 100-fold higher than the radioactive dexamethasone, or 5,000 nM). Dexamethasone at the Fraction Number FIGURE 1 ER, AR, and GLUC R in dog aorta. Aortas were excised from three different dogs and cytosols were prepared and incubated 4 (30) , were able to suppress R1881 binding. Because of the affinity of R1881 for progestin binding sites, we routinely add unlabeled triamcinolone to cytosols when AR are being measured (36) . This serves to mask glucocorticoid and progestin binding sites, so that only androgen receptors are measured. Despite cross-reactivity, we chose to use [3H]R1881 as the radioactive ligand for demonstrating AR because it does not bind sex steroid binding globulin, is not metabolized by 3a-hydroxysteroid dehydrogenases in cytosols at 0°C, and has a high affinity for receptors (28, 34, 36, 37) . Dihydrotestosterone, the physiologic androgen, does not have these properties (it is metabolized at 0°C even in the absence of added coenzymes [38] ), which often limits its use as a ligand in receptor assays (36) .
Location of receptors in blood vessel walls. The aorta is a complex structure composed of three layers. These are, from within outward, the intima, media, and adventitia. In an attempt to localize the cell type that contains the steroid receptors, we measured receptors in an intact aorta, and in an adjoining section of aorta from which the intima was stripped. Table  II shows that the intima-stripped aorta contained as many steroid binding sites as the intact vessel, and we conclude that the majority of receptors are not in the endothelium or in the fibrous tissue elements of the intima.
To localize receptors further, we next measured these in the inferior vena cava. In veins, in contrast to the aorta, the media is very thin, the adventitia is the thickest of the three layers, and the number of smooth muscle cells are greatly reduced. We reasoned that using veins would be analogous to removing the media from the aorta without disturbing the intima or adventitia. Fig. 3 shows the receptor levels in inferior venae cavae taken from male and female dogs. In veins of female dogs steroid receptor levels were (40) . We therefore oophorectomized dogs to remove most of the endogenous hormone, then injected them Fraction Number FIGURE 3 ER, AR, and GLUC R in inferior vena cava (IVC) of male and female dogs. Cytosols were prepared from spayed female (9.3 mg/ml protein) and intact male (10.9 mg/ml protein), incubated with hormones and centrifuged as described in Fig. 1 . Receptor levels in female were: ER, 50 fmol/mg DNA; AR, 38 fmol/mg DNA, and GLUC R, 150 fmol/mg DNA. with a physiological concentration of estradiol-17f# (5 gg/kg per d) for 7 d. Portions of the animals' uteruses were taken at surgery and again after hormone treatment to serve as controls. Fig. 4 shows the negative assay for PR in the aorta of a spayed female not treated with estradiol (-E). The figure also shows the PR induced by 1 (42, 43) ; similarly, in experimental animals, either pregnancy or administration of an estrogen-progesterone combination cause dilation and smooth muscle hypertrophy in systemic arteries (44) . In hypertensive male rats, progesterone increases and estrogen decreases aortic hypertrophy (13) . Progesterone also stimulates vascular proliferation in granulation tissue (45, 46) . Cavallero et al. (47) find that in cholesterol-fed rabbits, aortic smooth muscle replication is inhibited by exogenous glucocorticoids. Finally, thickening and hardening of blood vessels in vascular diseases is largely a fibrotic process, and sex steroids have been implicated in the control of collagen and elastin synthesis in these vessels: in general it seems that progesterone and androgens increase (13) (14) (15) and estrogens decrease (15, 48) collagen and elastin deposition in aortic smooth muscle cells in vivo and in culture. In sum, the data point to an inhibitory role for estrogens and glucocorticoids, and a stimulatory role for androgens and progestins, in vascular smooth muscle proliferative and/or hypertrophic activity.
Pregnancy, sex hormones, and glucocorticoids also have known hemodynamic effects. In pregnancy, in addition to increases in plasma volume, cardiac output, and stroke volume (49) (50) (51) there is redistribution of the cardiac output with substantial increase in blood flow to the uterus (52), kidneys (53), skin (54), nasal mucous membranes (55) , and probably the breasts. In nonpregnant women, oral contraceptives containing estrogen and progesterone increase plasma volume, cardiac output, stroke volume (10), and forearm blood flow (56) . There are numerous reports of systemic hypertension due to oral contraceptive agents (10, 57, 58) . In animal studies, cardiac output is increased by acute estrogen administration and decreased by progesterone (11, 59) . With chronic administration to animals, systemic blood pressure is increased by estrogen and decreased by progesterone (11, 12, 59 ). In regional vascular beds, estrogen causes vasodilation of uterine, umbilical, and skin vessels (60, 61) . A direct effect of estrogen has been described on the membrane potential of vascular smooth muscle (62) . In human and animal studies, glucocorticoids cause systemic hypertension (16) (17) (18) and potentiate the cardiovascular effects of catecholamines (63) . Finally, according to Baker et al. (64) there are androgen-mediated sex differences in the depressor response to arachidonic acid in rats.
There has been considerable epidemiological evidence linking sex and sex hormones to the incidence of certain cardiovascular disorders. Coronary artery disease is much less common in premenopausal women than in men of the same ages but the sex difference narrows considerably after the menopause when production of estrogens or progestins by women is markedly reduced (1) (2) (3) (4) . Although normal levels of endogenous estrogen or progesterone may protect women against atherosclerosis there is evidence that administration of exogenous female sex hormones may have opposite effects. There appears to be an increased incidence of acute myocardial infarction in premenopausal women taking birth control pills (6, 7) . Men taking estrogens have a marked increase in the incidence of acute myocardial infarctions and strokes (8, 9) . Hypertension during pregnancy or associated with use of oral contraceptives by women is a well-known problem (10, 57, 58) , and there is some evidence of an increased incidence of venous thromboembolism with oral contraceptives (65) . Diseases associated with high endogenous glucocorticoid production or treatment with glucocorticoids are both commonly associated with systemic hypertension (18) .
Our studies demonstrate that mechanisms exist for direct interactions of steroid hormones with blood vessel walls. We have shown that the canine aorta contains specific receptors for four classes of steroid hormones: estrogens, androgens, progestins, and glucocorticoids. Estrogen binding has previously been described in dog coronary arteries (62) , in rat aortic smooth muscle cells in culture (66) and, by autoradiography, in the media of muscle cells of rat uterine and renal arteries (67) . Low levels of ER may also be present in vascular endothelial cells (68) . To our knowledge, receptors for the other steroid hormones have not been previously described in vascular tissues.
We find that, in canine aorta, glucocorticoid receptors are present in high concentrations. The low dissociation constants, measured by Scatchard analysis, are evidence of high binding affinity of the receptor for ligand. ER and AR are present in lower concentrations but are of even higher binding affinity and are highly specific in competition studies. Cytoplasmic PR were not present in male canine aortas or nonpregnant female aortas. However, low levels of specific receptors were induced in ovariectomized female dogs treated with physiological estradiol concentrations. The receptors for the various steroid hormones are probably not in the intima since they persist when this layer is removed. Furthermore, since receptor levels were markedly lowered in veins, their most likely location is in the smooth muscle of the medial layer of the artery.
It is of interest to speculate on the physiological role of the steroid receptors in the vascular bed. We have found (unpublished observations) that other systemic arteries, including coronary, pulmonary, and carotid arteries, also contain receptors. It is possible, in view of their location in the media, that steroids, acting through their receptors, modulate smooth muscle tone in some vascular beds. They may also in some way influence development of atherosclerosis since smooth muscle migration and proliferation appear to play a major role in the pathogenesis of this disease.
